Drug Trial Radar · NCT02672332
P3 Study in Acne Comparing Once Daily SB204 and Vehicle
Last checked: Nov 19, 2026Latest source record: Jul 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,307
Actual
Start
Feb 22, 2016
Primary completion
Dec 2016
Study completion Dec 21, 2016
Sponsor
- Lead sponsor
- Novan, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Chiltern International Inc.
- First posted
- Feb 3, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 9 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 12 week, multi-center, double-blinded, randomized, vehicle-controlled, parallel group, study to be conducted in approximately 1300 subjects with acne vulgaris in the US.
Conditions
- Acne Vulgaris
Interventions
SB204 4%Drug
Once daily
Vehicle GelDrug
Placebo comparator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute Change From Baseline in Inflammatory Lesion CountsTime frame: Baseline and Week 12
- Absolute Change From Baseline in Non-inflammatory Lesion CountsTime frame: Baseline and Week 12
- Proportion of Subjects With Investigator Global Assessment (IGA) Success at Week 12Time frame: Baseline and Week 12
Locations
55 sites in 1 country. Site status is shown where the registry gives one.
CIL #146
Anaheim, California
CIL #118
Encinitas, California
CIL #186
Fresno, California
CIL #210
Fresno, California
CIL #209
Oceanside, California
CIL #161
San Diego, California
CIL #113
San Diego, California
CIL #199
Santa Rosa, California
CIL #103
Boca Raton, Florida
CIL #173
Hialeah, Florida
CIL #212
Homestead, Florida
CIL #222
Lauderdale Lakes, Florida
CIL #157
Miami, Florida
CIL #177
North Miami Beach, Florida
CIL #150
Orlando, Florida
CIL #172
Orlando, Florida
CIL #203
Ormond Beach, Florida
CIL #211
South Miami, Florida
CIL #229
Tampa, Florida
CIL #153
Wellington, Florida
Cil # 179
Chicago, Illinois
CIL #215
Wichita, Kansas
CIL #117
Louisville, Kentucky
CIL #180
New Orleans, Louisiana
CIL #205
Glenn Dale, Maryland
CIL #230
Quincy, Massachusetts
CIL #112
Detroit, Michigan
CIL #149
Troy, Michigan
CIL #225
Saint Joseph, Missouri
CIL #187
St Louis, Missouri
CIL #140
Omaha, Nebraska
CIL #182
Las Vegas, Nevada
CIL #201
Berlin, New Jersey
CIL #141
Montclair, New Jersey
CIL #156
Albuquerque, New Mexico
CIL #107
New York, New York
CIL #108
Rochester, New York
CIL #104
Stony Brook, New York
CIL #193
High Point, North Carolina
CIL #166
Winston-Salem, North Carolina
Showing 40 of 55 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.